PAVmed (NASDAQ:PAVM) Posts Quarterly Earnings Results, Beats Expectations By $4.40 EPS
PAVmed (NASDAQ:PAVM – Get Free Report) issued its quarterly earnings data on Friday. The company reported ($0.10) earnings per share for the quarter, topping the consensus estimate of ($4.50) by $4.40, FiscalAI reports. The firm had revenue of $0.05 million for the quarter, compared to analysts’ expectations of $0.03 million. PAVmed had a net margin […]
Journey Medical (NASDAQ:DERM) Posts Earnings Results, Beats Expectations By $0.02 EPS
Journey Medical (NASDAQ:DERM – Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.04) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.02, FiscalAI reports. The business had revenue of $16.08 million for the quarter, compared to analyst estimates of $18.86 million. Journey Medical had […]
BRP (NASDAQ:DOO) Posts Quarterly Earnings Results, Beats Expectations By $0.18 EPS
BRP (NASDAQ:DOO – Get Free Report) issued its quarterly earnings data on Thursday. The company reported $2.21 EPS for the quarter, beating analysts’ consensus estimates of $2.03 by $0.18, Briefing.com reports. BRP had a return on equity of 67.30% and a net margin of 0.45%.The business’s revenue for the quarter was up 16.0% compared to […]
Shoe Carnival (NASDAQ:SCVL) Posts Quarterly Earnings Results, Hits Expectations
Shoe Carnival (NASDAQ:SCVL – Get Free Report) announced its quarterly earnings data on Thursday. The company reported $0.33 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.33, FiscalAI reports. Shoe Carnival had a net margin of 5.06% and a return on equity of 8.75%. The company had revenue of $254.07 million […]
Cognition Therapeutics (NASDAQ:CGTX) Posts Earnings Results, Beats Expectations By $0.04 EPS
Cognition Therapeutics (NASDAQ:CGTX – Get Free Report) announced its earnings results on Thursday. The company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.04, FiscalAI reports. Here are the key takeaways from Cognition Therapeutics’ conference call: Cognition is prioritizing zervimesine for DLB psychosis after its phase II SHIMMER […]
Acumen Pharmaceuticals (NASDAQ:ABOS) Announces Earnings Results, Beats Expectations By $0.09 EPS
Acumen Pharmaceuticals (NASDAQ:ABOS – Get Free Report) issued its earnings results on Thursday. The company reported ($0.41) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.50) by $0.09, FiscalAI reports. Here are the key takeaways from Acumen Pharmaceuticals’ conference call: ALTITUDE-AD readout late 2026 — Acumen expects full efficacy and safety […]
Paychex (NASDAQ:PAYX) Announces Earnings Results, Beats Expectations By $0.03 EPS
Paychex (NASDAQ:PAYX – Get Free Report) issued its earnings results on Wednesday. The business services provider reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.68 by $0.03, Briefing.com reports. Paychex had a return on equity of 46.38% and a net margin of 26.45%.The business had revenue of $1.81 billion […]
Cabaletta Bio (NASDAQ:CABA) Posts Quarterly Earnings Results, Beats Expectations By $0.05 EPS
Cabaletta Bio (NASDAQ:CABA – Get Free Report) posted its quarterly earnings results on Monday. The company reported ($0.40) earnings per share for the quarter, topping the consensus estimate of ($0.45) by $0.05, FiscalAI reports. Cabaletta Bio Stock Down 3.3% Shares of NASDAQ CABA opened at $2.94 on Monday. The firm has a market cap of […]
Xilio Therapeutics (NASDAQ:XLO) Posts Quarterly Earnings Results, Beats Expectations By $2.49 EPS
Xilio Therapeutics (NASDAQ:XLO – Get Free Report) issued its quarterly earnings data on Monday. The company reported $0.81 earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.68) by $2.49, FiscalAI reports. The company had revenue of $13.69 million during the quarter, compared to the consensus estimate of $10.90 million. Xilio Therapeutics […]
Eton Pharmaceuticals (NASDAQ:ETON) Posts Quarterly Earnings Results, Beats Expectations By $0.07 EPS
Eton Pharmaceuticals (NASDAQ:ETON – Get Free Report) issued its earnings results on Thursday. The company reported $0.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.12 by $0.07, FiscalAI reports. The firm had revenue of $21.28 million during the quarter, compared to analyst estimates of $20.58 million. Eton Pharmaceuticals had a […]
Curis (NASDAQ:CRIS) Posts Earnings Results, Beats Expectations By $1.66 EPS
Curis (NASDAQ:CRIS – Get Free Report) announced its quarterly earnings data on Thursday. The biotechnology company reported $1.23 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.43) by $1.66, FiscalAI reports. The company had revenue of $1.14 million for the quarter, compared to analysts’ expectations of $3.25 million. Here are the key […]
Duluth (NASDAQ:DLTH) Announces Earnings Results, Beats Expectations By $0.14 EPS
Duluth (NASDAQ:DLTH – Get Free Report) issued its earnings results on Thursday. The company reported $0.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.09 by $0.14, FiscalAI reports. The business had revenue of $215.89 million during the quarter, compared to analysts’ expectations of $210.65 million. Duluth had a negative return […]
Boyd Group Services (NYSE:BGSI) Posts Earnings Results, Beats Expectations By $0.27 EPS
Boyd Group Services (NYSE:BGSI – Get Free Report) announced its quarterly earnings data on Wednesday. The company reported $0.90 EPS for the quarter, topping analysts’ consensus estimates of $0.63 by $0.27, Zacks reports. Boyd Group Services had a net margin of 0.52% and a return on equity of 3.91%. Boyd Group Services Stock Performance Boyd […]
Marker Therapeutics (NASDAQ:MRKR) Posts Earnings Results, Beats Expectations By $0.17 EPS
Marker Therapeutics (NASDAQ:MRKR – Get Free Report) announced its quarterly earnings results on Wednesday. The company reported ($0.04) earnings per share for the quarter, beating the consensus estimate of ($0.21) by $0.17, FiscalAI reports. The business had revenue of $1.10 million during the quarter, compared to analysts’ expectations of $0.68 million. Marker Therapeutics had a […]
Elbit Systems (NASDAQ:ESLT) Posts Earnings Results, Beats Expectations By $0.33 EPS
Elbit Systems (NASDAQ:ESLT – Get Free Report) announced its quarterly earnings data on Tuesday. The aerospace company reported $3.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.23 by $0.33, Zacks reports. Elbit Systems had a net margin of 5.91% and a return on equity of 15.04%. The company had revenue […]
Comtech Telecommunications (NASDAQ:CMTL) Posts Quarterly Earnings Results, Beats Expectations By $0.12 EPS
Comtech Telecommunications (NASDAQ:CMTL – Get Free Report) announced its earnings results on Monday. The communications equipment provider reported ($0.18) EPS for the quarter, beating the consensus estimate of ($0.30) by $0.12, FiscalAI reports. Comtech Telecommunications had a negative net margin of 4.60% and a positive return on equity of 8.35%. The company had revenue of […]
Adecoagro (NYSE:AGRO) Posts Earnings Results, Beats Expectations By $0.05 EPS
Adecoagro (NYSE:AGRO – Get Free Report) announced its earnings results on Monday. The company reported ($0.04) EPS for the quarter, topping the consensus estimate of ($0.09) by $0.05, FiscalAI reports. The business had revenue of $415.94 million during the quarter, compared to analysts’ expectations of $371.95 million. Adecoagro had a net margin of 1.67% and […]
Orchestra BioMed (NASDAQ:OBIO) Posts Quarterly Earnings Results, Beats Expectations By $0.64 EPS
Orchestra BioMed (NASDAQ:OBIO – Get Free Report) released its earnings results on Thursday. The company reported $0.26 EPS for the quarter, topping analysts’ consensus estimates of ($0.38) by $0.64, FiscalAI reports. The company had revenue of $30.92 million for the quarter, compared to analysts’ expectations of $0.93 million. Orchestra BioMed had a negative return on […]
last updated on 28 Mar 01:02